TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2010-05717
- Event Type
- Injury
- Date Received
- January 10, 2011
- Date of Event
- November 11, 2005
- Report Date
- December 13, 2010
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P030025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).
SAME CASE AS MFR# 2134265-2010-05715 AND 2134265-2010-05716. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE STENT THROMBOSIS OCCURRED. THREE TAXUS EXPRESS2 STENTS, SIZES 2.75X28MM, 2.72X28MM AND 2.50X24MM, WERE IMPLANTED IN THE RIGHT CORONARY ARTERY (RCA). SIX MONTHS LATER THE STENTS THROMBOSED AND THE PATIENT UNDERWENT OPEN HEART SURGERY. FOUR AND HALF YEARS LATER AN ADDITIONAL TAXUS STENT WAS IMPLANTED IN THE LEFT MAIN ARTERY (LM). IT WAS NOTED THAT THE LM HAD NOT BEEN BYPASSED BEFORE. THE PATIENT'S CURRENT CONDITION IS OKAY. ADDITIONAL INFORMATION WAS REQUESTED AND IS NOT AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | H7493896824250 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention | 2.50X24MM TAXUS EXPRESS2 STENT| 2.75X28MM TAXUS EXPRESS2 STENT |